GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2)

 OSBL2_HUMAN             Reviewed;         480 AA.
Q9H1P3; A8K736; Q6IBT0; Q9BZB1; Q9Y4B8;
11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
01-MAR-2001, sequence version 1.
13-FEB-2019, entry version 145.
RecName: Full=Oxysterol-binding protein-related protein 2;
Short=ORP-2;
Short=OSBP-related protein 2;
Name=OSBPL2; Synonyms=KIAA0772, ORP2;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
PubMed=11279184; DOI=10.1074/jbc.M101204200;
Xu Y., Liu Y., Ridgway N.D., McMaster C.R.;
"Novel members of the human oxysterol-binding protein family bind
phospholipids and regulate vesicle transport.";
J. Biol. Chem. 276:18407-18414(2001).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
PubMed=11735225; DOI=10.1006/geno.2001.6663;
Jaworski C.J., Moreira E., Li A., Lee R., Rodriguez I.R.;
"A family of 12 human genes containing oxysterol-binding domains.";
Genomics 78:185-196(2001).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
TISSUE=Brain;
PubMed=9872452; DOI=10.1093/dnares/5.5.277;
Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
Kotani H., Nomura N., Ohara O.;
"Prediction of the coding sequences of unidentified human genes. XI.
The complete sequences of 100 new cDNA clones from brain which code
for large proteins in vitro.";
DNA Res. 5:277-286(1998).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
TISSUE=Rectum;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
"Cloning of human full open reading frames in Gateway(TM) system entry
vector (pDONR201).";
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORMS 1 AND 2).
PubMed=11780052; DOI=10.1038/414865a;
Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
Rogers J.;
"The DNA sequence and comparative analysis of human chromosome 20.";
Nature 414:865-871(2001).
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Lung;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[9]
NUCLEOTIDE SEQUENCE [MRNA] OF 1-116 (ISOFORM 1).
PubMed=11483621;
Lehto M., Laitinen S., Chinetti G., Johansson M., Ehnholm C.,
Staels B., Ikonen E., Olkkonen V.M.;
"The OSBP-related protein family in humans.";
J. Lipid Res. 42:1203-1213(2001).
[10]
FUNCTION, AND MUTAGENESIS OF MET-93; PHE-103; LYS-150; PHE-152 AND
ILE-249.
PubMed=17428193; DOI=10.1042/BJ20070176;
Suchanek M., Hynynen R., Wohlfahrt G., Lehto M., Johansson M.,
Saarinen H., Radzikowska A., Thiele C., Olkkonen V.M.;
"The mammalian oxysterol-binding protein-related proteins (ORPs) bind
25-hydroxycholesterol in an evolutionarily conserved pocket.";
Biochem. J. 405:473-480(2007).
[11]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21269460; DOI=10.1186/1752-0509-5-17;
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
"Initial characterization of the human central proteome.";
BMC Syst. Biol. 5:17-17(2011).
[12]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=22814378; DOI=10.1073/pnas.1210303109;
Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
Aldabe R.;
"N-terminal acetylome analyses and functional insights of the N-
terminal acetyltransferase NatB.";
Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
[13]
INTERACTION WITH DIAPH1, AND IDENTIFICATION BY MASS SPECTROMETRY.
PubMed=23325789; DOI=10.1091/mbc.E12-08-0597;
Li D., Dammer E.B., Lucki N.C., Sewer M.B.;
"cAMP-stimulated phosphorylation of diaphanous 1 regulates protein
stability and interaction with binding partners in adrenocortical
cells.";
Mol. Biol. Cell 24:848-857(2013).
[14]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-20, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Liver;
PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
Wang L., Ye M., Zou H.;
"An enzyme assisted RP-RPLC approach for in-depth analysis of human
liver phosphoproteome.";
J. Proteomics 96:253-262(2014).
[15]
INVOLVEMENT IN DFNA67.
PubMed=25077649; DOI=10.1038/gim.2014.90;
Xing G., Yao J., Wu B., Liu T., Wei Q., Liu C., Lu Y., Chen Z.,
Zheng H., Yang X., Cao X.;
"Identification of OSBPL2 as a novel candidate gene for progressive
nonsyndromic hearing loss by whole-exome sequencing.";
Genet. Med. 17:210-218(2015).
[16]
INVOLVEMENT IN DFNA67.
PubMed=25759012; DOI=10.1186/s13023-015-0238-5;
Thoenes M., Zimmermann U., Ebermann I., Ptok M., Lewis M.A.,
Thiele H., Morlot S., Hess M.M., Gal A., Eisenberger T., Bergmann C.,
Nuernberg G., Nuernberg P., Steel K.P., Knipper M., Bolz H.J.;
"OSBPL2 encodes a protein of inner and outer hair cell stereocilia and
is mutated in autosomal dominant hearing loss (DFNA67).";
Orphanet J. Rare Dis. 10:15-15(2015).
-!- FUNCTION: Binds phospholipids; exhibits strong binding to
phosphatidic acid and weak binding to phosphatidylinositol 3-
phosphate (PubMed:11279184). Binds 25-hydroxycholesterol
(PubMed:17428193). {ECO:0000269|PubMed:11279184,
ECO:0000269|PubMed:17428193}.
-!- SUBUNIT: Interacts with DIAPH1. {ECO:0000269|PubMed:23325789}.
-!- INTERACTION:
Q9P0L0:VAPA; NbExp=3; IntAct=EBI-2828285, EBI-1059156;
Q53XM7:VAPB; NbExp=3; IntAct=EBI-2828285, EBI-10178947;
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=Q9H1P3-1; Sequence=Displayed;
Name=2;
IsoId=Q9H1P3-2; Sequence=VSP_003781;
-!- TISSUE SPECIFICITY: Widely expressed.
-!- DISEASE: Deafness, autosomal dominant, 67 (DFNA67) [MIM:616340]: A
form of non-syndromic sensorineural hearing loss. Sensorineural
deafness results from damage to the neural receptors of the inner
ear, the nerve pathways to the brain, or the area of the brain
that receives sound information. {ECO:0000269|PubMed:25077649,
ECO:0000269|PubMed:25759012}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the OSBP family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=BAA34492.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AY028168; AAK18044.1; -; mRNA.
EMBL; AF392447; AAL40660.1; -; mRNA.
EMBL; AB018315; BAA34492.2; ALT_INIT; mRNA.
EMBL; AK291851; BAF84540.1; -; mRNA.
EMBL; CR456722; CAG33003.1; -; mRNA.
EMBL; AL354836; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471077; EAW75377.1; -; Genomic_DNA.
EMBL; CH471077; EAW75379.1; -; Genomic_DNA.
EMBL; BC000296; AAH00296.1; -; mRNA.
EMBL; BC004455; AAH04455.1; -; mRNA.
EMBL; AF331963; AAG53416.1; -; mRNA.
CCDS; CCDS13494.1; -. [Q9H1P3-2]
CCDS; CCDS13495.1; -. [Q9H1P3-1]
RefSeq; NP_055650.1; NM_014835.3. [Q9H1P3-2]
RefSeq; NP_653081.1; NM_144498.2. [Q9H1P3-1]
RefSeq; XP_016883654.1; XM_017028165.1. [Q9H1P3-1]
UniGene; Hs.473254; -.
PDB; 5ZM8; X-ray; 2.70 A; A/B=49-480.
PDBsum; 5ZM8; -.
ProteinModelPortal; Q9H1P3; -.
SMR; Q9H1P3; -.
BioGrid; 115216; 12.
ELM; Q9H1P3; -.
IntAct; Q9H1P3; 10.
STRING; 9606.ENSP00000316649; -.
SwissLipids; SLP:000001533; -.
iPTMnet; Q9H1P3; -.
PhosphoSitePlus; Q9H1P3; -.
BioMuta; OSBPL2; -.
DMDM; 20139174; -.
EPD; Q9H1P3; -.
jPOST; Q9H1P3; -.
MaxQB; Q9H1P3; -.
PaxDb; Q9H1P3; -.
PeptideAtlas; Q9H1P3; -.
PRIDE; Q9H1P3; -.
ProteomicsDB; 80434; -.
ProteomicsDB; 80435; -. [Q9H1P3-2]
DNASU; 9885; -.
Ensembl; ENST00000313733; ENSP00000316649; ENSG00000130703. [Q9H1P3-1]
Ensembl; ENST00000358053; ENSP00000350755; ENSG00000130703. [Q9H1P3-2]
Ensembl; ENST00000643412; ENSP00000494549; ENSG00000130703. [Q9H1P3-1]
Ensembl; ENST00000643981; ENSP00000495379; ENSG00000130703. [Q9H1P3-1]
GeneID; 9885; -.
KEGG; hsa:9885; -.
UCSC; uc002yck.3; human. [Q9H1P3-1]
CTD; 9885; -.
DisGeNET; 9885; -.
EuPathDB; HostDB:ENSG00000130703.15; -.
GeneCards; OSBPL2; -.
HGNC; HGNC:15761; OSBPL2.
HPA; HPA041127; -.
HPA; HPA042659; -.
MalaCards; OSBPL2; -.
MIM; 606731; gene.
MIM; 616340; phenotype.
neXtProt; NX_Q9H1P3; -.
OpenTargets; ENSG00000130703; -.
Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
PharmGKB; PA32827; -.
eggNOG; KOG1737; Eukaryota.
eggNOG; ENOG410XP9E; LUCA.
GeneTree; ENSGT00940000158762; -.
HOGENOM; HOG000231233; -.
HOVERGEN; HBG053374; -.
InParanoid; Q9H1P3; -.
KO; K20174; -.
OMA; EWRTRWF; -.
OrthoDB; 863978at2759; -.
PhylomeDB; Q9H1P3; -.
Reactome; R-HSA-192105; Synthesis of bile acids and bile salts.
ChiTaRS; OSBPL2; human.
GeneWiki; OSBPL2; -.
GenomeRNAi; 9885; -.
PRO; PR:Q9H1P3; -.
Proteomes; UP000005640; Chromosome 20.
Bgee; ENSG00000130703; Expressed in 226 organ(s), highest expression level in skin of abdomen.
ExpressionAtlas; Q9H1P3; baseline and differential.
Genevisible; Q9H1P3; HS.
GO; GO:0005829; C:cytosol; IBA:GO_Central.
GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
GO; GO:0016020; C:membrane; IBA:GO_Central.
GO; GO:0015485; F:cholesterol binding; IDA:BHF-UCL.
GO; GO:0008289; F:lipid binding; IBA:GO_Central.
GO; GO:0032934; F:sterol binding; IBA:GO_Central.
GO; GO:0015248; F:sterol transporter activity; IBA:GO_Central.
GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
InterPro; IPR037239; OSBP_sf.
InterPro; IPR000648; Oxysterol-bd.
InterPro; IPR018494; Oxysterol-bd_CS.
PANTHER; PTHR10972; PTHR10972; 1.
Pfam; PF01237; Oxysterol_BP; 1.
SUPFAM; SSF144000; SSF144000; 1.
PROSITE; PS01013; OSBP; 1.
1: Evidence at protein level;
3D-structure; Alternative splicing; Complete proteome; Deafness;
Lipid transport; Lipid-binding; Non-syndromic deafness;
Phosphoprotein; Reference proteome; Transport.
CHAIN 1 480 Oxysterol-binding protein-related protein
2.
/FTId=PRO_0000100369.
MOD_RES 19 19 Phosphoserine.
{ECO:0000244|PubMed:24275569}.
MOD_RES 20 20 Phosphoserine.
{ECO:0000244|PubMed:24275569}.
VAR_SEQ 13 24 Missing (in isoform 2).
{ECO:0000303|PubMed:11279184,
ECO:0000303|PubMed:11735225,
ECO:0000303|PubMed:14702039,
ECO:0000303|PubMed:9872452}.
/FTId=VSP_003781.
MUTAGEN 93 93 M->K: Does not significantly impair 25-
hydroxycholesterol binding.
{ECO:0000269|PubMed:17428193}.
MUTAGEN 103 103 F->W: Does not significantly impair 25-
hydroxycholesterol binding.
{ECO:0000269|PubMed:17428193}.
MUTAGEN 150 150 K->A: Reduces 25-hydroxycholesterol
binding. {ECO:0000269|PubMed:17428193}.
MUTAGEN 152 152 F->D: Does not significantly impair 25-
hydroxycholesterol binding.
{ECO:0000269|PubMed:17428193}.
MUTAGEN 249 249 I->W: Reduces 25-hydroxycholesterol
binding. {ECO:0000269|PubMed:17428193}.
SEQUENCE 480 AA; 55201 MW; A93D1B389D0A2740 CRC64;
MNGEEEFFDA VTGFDSDNSS GEFSEANQKV TGMIDLDTSK NNRIGKTGER PSQENGIQKH
RTSLPAPMFS RSDFSVWTIL KKCVGLELSK ITMPIAFNEP LSFLQRITEY MEHVYLIHRA
SCQPQPLERM QSVAAFAVSA VASQWERTGK PFNPLLGETY ELIREDLGFR FISEQVSHHP
PISAFHSEGL NHDFLFHGSI YPKLKFWGKS VEAEPRGTIT LELLKHNEAY TWTNPTCCVH
NVIIGKLWIE QYGTVEILNH RTGHKCVLHF KPCGLFGKEL HKVEGHIQDK NKKKLFMIYG
KWTECLWGID PVSYESFKKQ ERRGDHLRKA KLDEDSGKAD SDVADDVPVA QETVQVIPGS
KLLWRINTRP PNSAQMYNFT SFTVSLNELE TGMEKTLPPT DCRLRPDIRG MENGNMDLAS
QEKERLEEKQ REARRERAKE EAEWQTRWFY PGNNPYTGTP DWLYAGDYFE RNFSDCPDIY


Related products :

Catalog number Product name Quantity
EIAAB29238 Homo sapiens,Human,KIAA1534,OBPH1,ORP5,ORP-5,OSBPL5,OSBP-related protein 5,Oxysterol-binding protein homolog 1;,Oxysterol-binding protein-related protein 5
EIAAB29249 Homo sapiens,Human,KIAA1664,ORP4,ORP-4,OSBP2,OSBPL4,OSBP-related protein 4,Oxysterol-binding protein 2,Oxysterol-binding protein-related protein 4
EIAAB29237 Mouse,Mus musculus,Obph1,ORP-5,Osbp2,Osbpl5,OSBP-related protein 5,Oxysterol-binding protein homolog 1,Oxysterol-binding protein-related protein 5
EIAAB29227 Homo sapiens,Human,ORP10,ORP-10,OSBP9,OSBPL10,OSBP-related protein 10,Oxysterol-binding protein-related protein 10
EIAAB29228 Homo sapiens,Human,ORP11,ORP-11,OSBP12,OSBPL11,OSBP-related protein 11,Oxysterol-binding protein-related protein 11
EIAAB29234 Homo sapiens,Human,KIAA0772,ORP2,ORP-2,OSBPL2,OSBP-related protein 2,Oxysterol-binding protein-related protein 2
EIAAB29244 Homo sapiens,Human,ORP9,ORP-9,OSBP4,OSBPL9,OSBP-related protein 9,Oxysterol-binding protein-related protein 9
EIAAB29236 Homo sapiens,Human,KIAA0704,ORP3,ORP-3,OSBP3,OSBPL3,OSBP-related protein 3,Oxysterol-binding protein-related protein 3
EIAAB29242 Homo sapiens,Human,KIAA1451,ORP8,ORP-8,OSBP10,OSBPL8,OSBP-related protein 8,Oxysterol-binding protein-related protein 8
EIAAB29231 Homo sapiens,Human,ORP1,ORP-1,OSBP8,OSBPL1,OSBPL1A,OSBPL1B,OSBP-related protein 1,Oxysterol-binding protein-related protein 1
EIAAB29230 Mouse,Mus musculus,Orp1,ORP-1,Orp1a,Osbpl1a,OSBP-related protein 1,Oxysterol-binding protein-related protein 1
EIAAB29240 Homo sapiens,Human,ORP6,ORP-6,OSBPL6,OSBP-related protein 6,Oxysterol-binding protein-related protein 6
EIAAB29241 Homo sapiens,Human,ORP7,ORP-7,OSBPL7,OSBP-related protein 7,Oxysterol-binding protein-related protein 7
EIAAB29232 Orp1,ORP-1,Osbpl1a,OSBP-related protein 1,Oxysterol-binding protein-related protein 1,Rat,Rattus norvegicus
EIAAB29243 Mouse,Mus musculus,Orp9,ORP-9,Osbpl9,OSBP-related protein 9,Oxysterol-binding protein-related protein 9
EIAAB29235 Mouse,Mus musculus,Orp3,ORP-3,Osbpl3,OSBP-related protein 3,Oxysterol-binding protein-related protein 3
EIAAB29233 Mouse,Mus musculus,ORP-2,Osbpl2,OSBP-related protein 2,Oxysterol-binding protein-related protein 2
EIAAB29229 Mouse,Mus musculus,ORP-11,Osbpl11,OSBP-related protein 11,Oxysterol-binding protein-related protein 11
EIAAB29239 Mouse,Mus musculus,ORP-6,Osbpl6,OSBP-related protein 6,Oxysterol-binding protein-related protein 6
CSB-EL017253HU Human Oxysterol-binding protein-related protein 8(OSBPL8) ELISA kit 96T
CSB-EL017254MO Mouse Oxysterol-binding protein-related protein 9(OSBPL9) ELISA kit 96T
CSB-EL017251MO Mouse Oxysterol-binding protein-related protein 6(OSBPL6) ELISA kit 96T
CSB-EL017252HU Human Oxysterol-binding protein-related protein 7(OSBPL7) ELISA kit 96T
CSB-EL017254HU Human Oxysterol-binding protein-related protein 9(OSBPL9) ELISA kit 96T
CSB-EL017250MO Mouse Oxysterol-binding protein-related protein 5(OSBPL5) ELISA kit 96T

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP731: Sterol regulatory element binding protein related
WP2199: Seed Development
WP2272: Pathogenic Escherichia coli infection
WP1531: Vitamin D synthesis
WP1616: ABC transporters
WP2292: Chemokine signaling pathway
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1624: Bacterial secretion system
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1657: Glycerolipid metabolism
WP1659: Glycine, serine and threonine metabolism
WP1661: Glyoxylate and dicarboxylate metabolism
WP1663: Homologous recombination
WP1665: Limonene and pinene degradation
WP1672: Mismatch repair

Related Genes :
[OSBPL3 KIAA0704 ORP3 OSBP3] Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3)
[OSBPL2 KIAA0772 ORP2] Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2)
[Osbpl8 Kiaa1451 Orp8] Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8)
[Osbpl3 Orp3] Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3)
[OSBP OSBP1] Oxysterol-binding protein 1
[gag-pol] Gag-Pol polyprotein (Pr180gag-pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10 (NC-pol); Protease p14 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p80 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[gag-pol] Gag-Pol polyprotein (Pr180gag-pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10 (NC-pol); Protease p14 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p80 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[gag-pol] Gag-Pol polyprotein (Pr180gag-pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10 (NC-pol); Protease p14 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p80 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[S 2] Spike glycoprotein (S glycoprotein) (E2) (Peplomer protein) [Cleaved into: Spike protein S1; Spike protein S2; Spike protein S2']
[1a] Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (Leader protein); Non-structural protein 2 (nsp2) (p65 homolog); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL2-PRO) (Papain-like proteinase) (PL-PRO) (SARS coronavirus main proteinase); Non-structural protein 4 (nsp4); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (nsp5); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7); Non-structural protein 8 (nsp8); Non-structural protein 9 (nsp9); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL); Non-structural protein 11 (nsp11)]
[Osbp Kiaa4220] Oxysterol-binding protein 1
[apr-1 K04G2.8] Adenomatous polyposis coli protein-related protein 1 (APC-related protein 1)
[AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6] Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)
[Hey2 Chf1 Herp Herp1 Hesr2 Hrt2] Hairy/enhancer-of-split related with YRPW motif protein 2 (HES-related repressor protein 2) (Hairy and enhancer of split-related protein 2) (HESR-2) (Hairy-related transcription factor 2) (HRT-2) (mHRT2) (Protein gridlock homolog)
[OSBP] Oxysterol-binding protein 1
[Atk TK] Tachykinins (AmTRP) (Tachykinin-related peptide) [Cleaved into: APTGHQEMQ-amide (AmTRP1) (Tachykinin-related peptide 1) (TRP1); ALMGFQGVR-amide (AmTRP2) (Tachykinin-related peptide 2) (TRP2); Brain peptide NSIINDVKNELFPEDIN; APMGFQGMR-amide 1 (AmTRP3) (Tachykinin-related peptide 3-1) (TRP3-1); Brain peptide ASFDDEYY; APMGFQGMR-amide 2 (AmTRP3) (Tachykinin-related peptide 3-2) (TRP3-2); Brain peptide SLEEILDEIK; Brain peptide SLEEILDEI; Brain peptide EILDEI; TTRFQDSRSKDVYLIDYPEDY-amide (AmTAP1) (Tachykinin-associated peptide 1); Brain peptide VLSMDGYQNILDKKDELLGEWE; Brain peptide APMGFYGT; APMGFYGTR-amide (AmTRP4) (Tachykinin-related peptide 4) (TRP4); Brain peptide IILDALEELD; Brain peptide ILDALEELD; Brain peptide GVMDFQIGLQ; ARMGFHGMR-amide (AmTRP5) (Tachykinin-related peptide 5) (TRP5); SPFRYLGAR-amide (AmTRP6) (Tachykinin-related peptide 6) (TRP6); NPRWEFRGKFVGVR-amide (AmTRP7) (Tachykinin-related peptide 7) (TRP7)]
[arpB arp2 DDB_G0272106] Actin-related protein 2 (Actin-like protein 2) (Actin-related protein B)
[RUNX1 AML1 CBFA2] Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit)
[KIN11 AKIN11 SNR1 SNRK1.2 At3g29160 MXE2.16] SNF1-related protein kinase catalytic subunit alpha KIN11 (AKIN11) (EC 2.7.11.1) (AKIN alpha-1) (AKINalpha1) (SNF1-related kinase 1.2) (SnRK1.2)
[HEY1 BHLHB31 CHF2 HERP2 HESR1 HRT1] Hairy/enhancer-of-split related with YRPW motif protein 1 (Cardiovascular helix-loop-helix factor 2) (CHF-2) (Class B basic helix-loop-helix protein 31) (bHLHb31) (HES-related repressor protein 1) (Hairy and enhancer of split-related protein 1) (HESR-1) (Hairy-related transcription factor 1) (HRT-1) (hHRT1)
[KIN10 AK21 AKIN10 SKIN10 SNR2 SNRK1.1 At3g01090 T4P13.22] SNF1-related protein kinase catalytic subunit alpha KIN10 (AKIN10) (EC 2.7.11.1) (AKIN alpha-2) (AKINalpha2) (SNF1-related kinase 1.1) (SnRK1.1)
[Nfe2l1 Nrf1] Endoplasmic reticulum membrane sensor NFE2L1 (Locus control region-factor 1) (LCR-F1) (Nuclear factor erythroid 2-related factor 1) (NF-E2-related factor 1) (NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) [Cleaved into: Transcription factor NRF1]
[AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5] Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B)
[S 3] Spike glycoprotein (S glycoprotein) (E2) (Peplomer protein) [Cleaved into: Spike protein S1; Spike protein S2; Spike protein S2']
[ECI2 DRS1 HCA88 PECI] Enoyl-CoA delta isomerase 2, mitochondrial (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)
[Tk CG14734] Tachykinins (dTk) [Cleaved into: Tachykinin-related peptide 1 (TK-1) (dTK-1) (APTSSFIGMR-amide); Tachykinin-associated peptide 1 (TAP1) (DEEHDTSEGNWLGSGPDPLDYADEEADSSYAEN-amide); Tachykinin-related peptide 2 (TK-2) (dTK-2) (APLAFVGLR-amide); Tachykinin-associated peptide 2 (TAP2) (FIPINNRLSDVLQSLEEERLRDSLLQDFFDRVAGRDGSAV-amide); Tachykinin-related peptide 3 (TK-3) (dTK-3) (APTGFTGMR-amide); Tachykinin-associated peptide 3 (TAP3) (Brain peptide PALLAGDDDAEADEATELQQ); Tachykinin-related peptide 4 (TK-4) (dTK-4) (APVNSFVGMR-amide); Tachykinin-associated peptide 4 (TAP4) (Brain peptide DVSHQHY); Tachykinin-associated peptide 5 (TAP5) (AALSDSYDLRGKQQRFADFNSKFVAVR-amide); Tachykinin-associated peptide 6 (TAP6) (Brain peptide SDLEGNGVGIGDDHEQALVHPWLYLWGE); Tachykinin-related peptide 5 (TK-5) (dTK-5) (APNGFLGMR-amide)]
[Smarcal1 Harp] SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (mharp) (Sucrose nonfermenting protein 2-like 1)
[ASK7 BIN2 DWF12 SK21 UCU1 At4g18710 F28A21.120] Shaggy-related protein kinase eta (EC 2.7.11.1) (ASK-eta) (Protein BRASSINOSTEROID INSENSITIVE 2) (Protein ULTRACURVATA 1) (Shaggy-related protein kinase 21) (AtSK21)
[Ptk2 Fadk Fak Fak1 Kiaa4203] Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)
[NFE2L1 HBZ17 NRF1 TCF11] Endoplasmic reticulum membrane sensor NFE2L1 (Locus control region-factor 1) (LCR-F1) (Nuclear factor erythroid 2-related factor 1) (NF-E2-related factor 1) (NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) (Protein NRF1, p120 form) (Transcription factor 11) (TCF-11) [Cleaved into: Transcription factor NRF1 (Protein NRF1, p110 form)]

Bibliography :
?>